Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1200/CCI.23.00072 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Time to Put Down the Phone-A Case for Structured Data Entry.
JCO Clin Cancer Inform
September 2023
Ariadne Labs, Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health, Boston, MA.
Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer.
Oncologist
March 2022
Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA.
Background: The outcomes of metastatic hormone-sensitive prostate cancer (mHSPC) have significantly improved through treatment intensification, yet Black representation in those studies is suboptimal.
Methods: A multi-institutional, retrospective analysis of Black men with mHSPC was conducted, focusing on baseline demographics, treatment patterns, genomic profiles, clinical outcomes including prostate-specific antigen response, time to castrate-resistant prostate cancer (CRPC), and subsequent treatments.
Results: A total of 107 patients, median age 64 years, 62% with de novo metastases at diagnosis and 64% with high-volume disease, were included.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!